NWIPB OpenIR
Hydrogen sulfide donors: Therapeutic potential in anti-atherosclerosis
Zhang, Honghua; Bai, Zhongjie; Zhu, Longqing; Liang, Yan; Fan, Xiaohong; Li, Junfang; Wen, Huaixiu; Shi, Tao; Zhao, Quanyi; Wang, Zhen
2020
发表期刊EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷号205
摘要Atherosclerosis (AS), an important cause of high mortality of cardiovascular disease, involves numerous pathophysiological processes, including endothelial cell damage, oxidative stress, inflammation, lipid deposition, vascular smooth muscle proliferation and migration, macrophage-derived foam cell formation, and platelet aggregation, and seriously endangers human health and safe of life. Hydrogen sulfide (H2S) was discovered as the third gaseous signaling molecule following nitric oxide (NO) and carbon monoxide (CO), and has been proposed to exert potentially significant effects in many physiological processes, especially in atherosclerosis. Compelling evidence suggests that malfunction of CSE/H2S pathway and downregulation of endogenous H2S level contribute to the pathogenesis of atherosclerosis, whereas exogenous supplementation of H2S can ameliorate many of atherogenic processes. The current knowledge on the anti-atherogenic role of H2S comes from the use of H2S donors and CSE or CBS inhibitors, or another more accurate genetic technology, including gene knockout and gene therapy studies. Among them H2S releasing donors have vast therapeutic potential in anti-atherosclerosis and are promising as one of the clinical strategies for atherosclerosis treatment. Based on the recent studies on therapeutic effects and mechanisms of H2S donors, this review focuses on the most recent advances of therapeutic potential of H2S donors in anti-atherosclerosis, especially synthetic organic donors, because sulfide salts can release H2S rapidly and lead to various adverse effects. In addition, the future of this domain is prospected. (C) 2020 Elsevier Masson SAS. All rights reserved.
关键词Hydrogen sulfide (H2S) Synthetic organic H2S donors Anti-Atherosclerosis Pathogenesis Therapeutic mechanism
文献类型期刊论文
条目标识符http://210.75.249.4/handle/363003/60220
专题中国科学院西北高原生物研究所
推荐引用方式
GB/T 7714
Zhang, Honghua,Bai, Zhongjie,Zhu, Longqing,et al. Hydrogen sulfide donors: Therapeutic potential in anti-atherosclerosis[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2020,205.
APA Zhang, Honghua.,Bai, Zhongjie.,Zhu, Longqing.,Liang, Yan.,Fan, Xiaohong.,...&Wang, Zhen.(2020).Hydrogen sulfide donors: Therapeutic potential in anti-atherosclerosis.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,205.
MLA Zhang, Honghua,et al."Hydrogen sulfide donors: Therapeutic potential in anti-atherosclerosis".EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 205(2020).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhang, Honghua]的文章
[Bai, Zhongjie]的文章
[Zhu, Longqing]的文章
百度学术
百度学术中相似的文章
[Zhang, Honghua]的文章
[Bai, Zhongjie]的文章
[Zhu, Longqing]的文章
必应学术
必应学术中相似的文章
[Zhang, Honghua]的文章
[Bai, Zhongjie]的文章
[Zhu, Longqing]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。